Cardiometabolic Risk Indicators That Distinguish Adults with Psychosis from the General Population, by Age and Gender
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiometabolic Risk Indicators That Distinguish Adults with Psychosis from the General Population, by Age and Gender
Authors
Keywords
Psychoses, Antipsychotics, Obesity, Health services research, Body mass index, Insulin resistance, Blood pressure, Cholesterol
Journal
PLoS One
Volume 8, Issue 12, Pages e82606
Publisher
Public Library of Science (PLoS)
Online
2013-12-19
DOI
10.1371/journal.pone.0082606
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Origins and Drivers of Insulin Resistance
- (2013) Andrew M.F. Johnson et al. CELL
- A Behavioral Weight-Loss Intervention in Persons with Serious Mental Illness
- (2013) Gail L. Daumit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis
- (2012) Cherrie A Galletly et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- People living with psychotic illness in 2010: The second Australian national survey of psychosis
- (2012) Vera A Morgan et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Life expectancy and cardiovascular mortality in persons with schizophrenia
- (2012) Thomas M. Laursen et al. CURRENT OPINION IN PSYCHIATRY
- Assessment and Treatment of Cardiovascular Risk in Prediabetes: Impaired Glucose Tolerance and Impaired Fasting Glucose
- (2011) Ralph A. DeFronzo et al. AMERICAN JOURNAL OF CARDIOLOGY
- A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
- (2011) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis
- (2011) Debra L. Foley et al. ARCHIVES OF GENERAL PSYCHIATRY
- Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation
- (2011) M. De Hert et al. BRITISH JOURNAL OF PSYCHIATRY
- Physical health disparities and mental illness: the scandal of premature mortality
- (2011) Graham Thornicroft BRITISH JOURNAL OF PSYCHIATRY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Endogenic and Iatrogenic Diabetes Mellitus in Drug-naïve Schizophrenia: The Role of Olanzapine and its Place in the Psychopharmacological Treatment Algorithm
- (2011) Dan Cohen et al. NEUROPSYCHOPHARMACOLOGY
- A Double Blind, Placebo-Controlled, Randomized Crossover Study of the Acute Metabolic Effects of Olanzapine in Healthy Volunteers
- (2011) Vance L. Albaugh et al. PLoS One
- Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices
- (2011) A. J. Mitchell et al. PSYCHOLOGICAL MEDICINE
- “Extended” Antipsychotic Dosing in the Maintenance Treatment of Schizophrenia
- (2010) Gary Remington et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients
- (2010) Jimmi Nielsen et al. NEUROPSYCHOPHARMACOLOGY
- Antipsychotic Dosing: How Much but also How Often?
- (2010) G. Remington et al. SCHIZOPHRENIA BULLETIN
- Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia
- (2009) Mihael H. Polymeropoulos et al. SCHIZOPHRENIA RESEARCH
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started